EMAIL THIS PAGE TO A FRIEND

Cancer research

Uncontrolled inflammation induced by AEG-1 promotes gastric cancer and poor prognosis.


PMID 25092897

Abstract

Gastric cancer is one of the most common causes of cancer-related death worldwide. Helicobacter pylori infection plays an important role in the development and progression of gastric cancer. The expression of astrocyte-elevated gene-1 (AEG-1) is increased in gastric cancer tissues, thereby contributing to the inflammatory response. We investigated whether and how AEG-1 regulated proinflammatory signaling in gastric cancer cells. We used human gastric cancer cell lines and athymic nude mice to investigate the role of AEG-1 in the regulation of the TLR4/nuclear factor-κB (NF-κB) signaling pathway and cancer invasion and compared the expression of AEG-1 and related proteins in 93 patients with gastric cancer by immunohistochemistry. In human gastric cancer cells, both AEG-1 and TLR4 could be induced by lipopolysaccharide (LPS) stimulation. AEG-1 was upregulated via LPS-TLR4 signaling and in turn promoted nuclear translocation of the NF-κB p65 subunit. At the same time, AEG-1 overexpression decreased the levels of suppressor of cytokine signaling (SOCS) protein SOCS-1, a negative regulator of the TLR4 pathway. Furthermore, nude mice engrafted with AEG-1/TLR4-expressing cells demonstrated larger tumor volumes than control animals. In patients with gastric cancer, the expression of AEG-1 correlated with that of TLR4, SOCS-1, and NF-κB and was higher in tumors compared with noncancerous adjacent tissues. Overall survival in patients with gastric cancer with simultaneous expression of AEG-1 and TLR4 was poor. Our results demonstrate that AEG-1 can promote gastric cancer progression by a positive feedback TLR4/NF-κB signaling-related mechanism, thus providing new mechanistic explanation for the role of inflammation in cancer progression.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1100404
Anti-RELA (51-65) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB4300294
Anti-RELA (Ab-254) antibody produced in rabbit, affinity isolated antibody
SAB4300295
Anti-RELA (Ab-276) antibody produced in rabbit, affinity isolated antibody
SAB4300506
Anti-RELA (Ab-311) antibody produced in rabbit, affinity isolated antibody
SAB4300296
Anti-RELA (Ab-435) antibody produced in rabbit, affinity isolated antibody
SAB4300297
Anti-RELA (Ab-468) antibody produced in rabbit, affinity isolated antibody
SAB4300442
Anti-RELA (Ab-505) antibody produced in rabbit, affinity isolated antibody
SAB4300469
Anti-RELA (Ab-529) antibody produced in rabbit, affinity isolated antibody
SAB4300298
Anti-RELA (Ab-536) antibody produced in rabbit, affinity isolated antibody
AV100779
Anti-RELA antibody produced in rabbit, IgG fraction of antiserum
SAB2101980
Anti-RELA antibody produced in rabbit, affinity isolated antibody
SAB2103066
Anti-RELA antibody produced in rabbit, affinity isolated antibody
EHU024601 MISSION® esiRNA, esiRNA human MTDH (esiRNA1)
EMU033821 MISSION® esiRNA, esiRNA targeting mouse Mtdh (esiRNA1)
SAB1404309
Monoclonal Anti-RELA antibody produced in mouse, clone 8G3, ascites fluid
SAB5300389
Monoclonal Anti-RELA antibody produced in mouse, clone 6H7, ascites fluid